Company Gyroscope Therapeutics Holdings plc
Equities
VISN
US40382N1037
Biotechnology & Medical Research
Business Summary
Number of employees: 179
Sales per Business
USD in Million | 2020 | Weight | Delta |
---|---|---|---|
Clinical - Stage Gene Therapy
100.0
%
| 1 | 100.0 % | - |
Sales per region
USD in Million | 2020 | Weight | Delta |
---|---|---|---|
United States
70.0
%
| 1 | 70.0 % | - |
United Kingdom
30.0
%
| 0 | 30.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/20/01 |
Ian Pitfield
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/20/01 |
Jane Hughes
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/19/01 |
Edward Lang
PRN | Corporate Officer/Principal | 44 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | - | |
Director/Board Member | 51 | - | |
Janet Hopkins
BRD | Director/Board Member | 60 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,229,659 | 28,937,362 ( 99.00 %) | 0 | 49.50 % |
Stock B | 1 | 29,229,659 | 0 | 0 |
Company contact information
Gyroscope Therapeutics Holdings Plc
Gunnels Wood Road
SG1 2FX, Stevenage
+44 14 3890 6770
Sector
1st Jan change | Capi. | |
---|---|---|
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |